Hude Dragičević, I.; Bašić-Kinda, S.; Markotić, H.; Morić-Perić, M.; Dujmović, D.; Radman, I.; Dreta, B.; Dotlić, S.; Ilić, I.; Galunić Bilić, L.;
et al. Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP). Medicina 2024, 60, 430.
https://doi.org/10.3390/medicina60030430
AMA Style
Hude Dragičević I, Bašić-Kinda S, Markotić H, Morić-Perić M, Dujmović D, Radman I, Dreta B, Dotlić S, Ilić I, Galunić Bilić L,
et al. Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP). Medicina. 2024; 60(3):430.
https://doi.org/10.3390/medicina60030430
Chicago/Turabian Style
Hude Dragičević, Ida, Sandra Bašić-Kinda, Helena Markotić, Martina Morić-Perić, Dino Dujmović, Ivo Radman, Barbara Dreta, Snježana Dotlić, Ivana Ilić, Lea Galunić Bilić,
and et al. 2024. "Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)" Medicina 60, no. 3: 430.
https://doi.org/10.3390/medicina60030430
APA Style
Hude Dragičević, I., Bašić-Kinda, S., Markotić, H., Morić-Perić, M., Dujmović, D., Radman, I., Dreta, B., Dotlić, S., Ilić, I., Galunić Bilić, L., Dobrenić, M., Kralik, M., & Aurer, I.
(2024). Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP). Medicina, 60(3), 430.
https://doi.org/10.3390/medicina60030430
